Sign in Register

Drug class

Mouth and Throat Antifungal Agents

Mouth and throat antifungal agents are an anatomical and therapeutic grouping of antifungal medications formulated specifically for topical application to the oropharyngeal mucosa. Read more about Mouth and Throat Antifungal Agents

26 drugs in this class 25 manufacturers

Related classes & indications

Antimalarial DrugsAnti-infectives · 223 prescription drugs Antiprotozoal AgentsAnti-infectives · 102 prescription drugs Oral CandidiasisTop indication · 84 prescription drugs

Showing 19–26 of 26 drugs

Sort

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS · CUTANEOUS CANDIDIASIS

NUCARE PHARMACE

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS · ORAL CANDIDIASIS ·+2

NIVAGEN PHARMAC

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS · ORAL CANDIDIASIS ·+2

PD-RX PHARM

CLOTRIMAZOLE

MOUTH AND THROAT ANTIFUNGAL AGENTS · TINEA CRURIS ·+5

Padagis US

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS · ORAL CANDIDIASIS ·+2

Avet Pharmaceuticals

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS · ORAL CANDIDIASIS ·+2

KANCHAN HEALTHC

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS · ORAL CANDIDIASIS ·+2

KESIN PHARMA

NYSTATIN

MOUTH AND THROAT ANTIFUNGAL AGENTS · ORAL CANDIDIASIS ·+2

CHARTWELL GOVER

Filter & compare in the drug finder → Opens the drug finder with Mouth and Throat Antifungal Agents preselected. Add indication or manufacturer filters there.

About Mouth and Throat Antifungal Agents.

Mouth and throat antifungal agents are an anatomical and therapeutic grouping of antifungal medications formulated specifically for topical application to the oropharyngeal mucosa.

This administrative and clinical category encompasses distinct chemical classes, primarily polyenes like nystatin and imidazoles like clotrimazole or miconazole, delivered via oral suspensions, lozenges, troches, or buccal tablets.

These agents function locally by altering fungal cell membrane integrity, either by binding ergosterol to cause cell leakage or by inhibiting ergosterol biosynthesis.

They are predominantly indicated for the treatment and prophylaxis of superficial mucosal fungal infections, most notably oropharyngeal candidiasis (oral thrush) in pediatric, geriatric, and immunocompromised patient populations.

goodrx.com
Mouth and throat antifungal agents are an anatomical and therapeutic grouping of antifungal medications formulated specifically for topical application to the oropharyngeal mucosa This administrative and clinical category encompasses distinct chemical classes, primarily polyenes like nystatin and imidazoles like clotrimazole or miconazole, delivered via oral suspensions, lozenges, troches, or buccal tablets
nih.gov
Mouth and throat antifungal agents are an anatomical and therapeutic grouping of antifungal medications formulated specifically for topical application to the oropharyngeal mucosa
fda.gov
This administrative and clinical category encompasses distinct chemical classes, primarily polyenes like nystatin and imidazoles like clotrimazole or miconazole, delivered via oral suspensions, lozenges, troches, or buccal tablets They are predominantly indicated for the treatment and prophylaxis of superficial mucosal fungal infections, most notably oropharyngeal candidiasis (oral thrush) in pediatric, geriatric, and immunocompromised patient populations
medlineplus.gov
This administrative and clinical category encompasses distinct chemical classes, primarily polyenes like nystatin and imidazoles like clotrimazole or miconazole, delivered via oral suspensions, lozenges, troches, or buccal tablets They are predominantly indicated for the treatment and prophylaxis of superficial mucosal fungal infections, most notably oropharyngeal candidiasis (oral thrush) in pediatric, geriatric, and immunocompromised patient populations
cdc.gov
These agents function locally by altering fungal cell membrane integrity, either by binding ergosterol to cause cell leakage or by inhibiting ergosterol biosynthesis
nih.gov
These agents function locally by altering fungal cell membrane integrity, either by binding ergosterol to cause cell leakage or by inhibiting ergosterol biosynthesis
nih.gov
They are predominantly indicated for the treatment and prophylaxis of superficial mucosal fungal infections, most notably oropharyngeal candidiasis (oral thrush) in pediatric, geriatric, and immunocompromised patient populations
nih.gov
They are predominantly indicated for the treatment and prophylaxis of superficial mucosal fungal infections, most notably oropharyngeal candidiasis (oral thrush) in pediatric, geriatric, and immunocompromised patient populations